The next stage of testing comes following successful animal trials in the Netherlands, which showed encouraging results.
Russian Federation has become the first nation to complete clinical trials of Covid-19 vaccine on humans, and the results have proven the medication's effectiveness, the media reported on Sunday.
The trials will not accept volunteers "until we receive approval from the Thai Food and Drug Administration and an ethics committee", Kiat said.
As of Friday, there have been 2,737,749 confirmed COVID-19 cases across the whole of Europe, according to the Statista online data collection portal. Citing Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical, and Vector-Borne Diseases at Sechenov University, the report mentioned that the study has been done to check vaccine's safety when given to humans and that has now been successfully done. Subsequent phases expand testing exponentially and can run into years before determining a vaccine is safe for mass production.
There are no approved vaccines for the virus that causes Covid-19, but 19 candidates are being trailed in humans globally. "Trials for the vaccine are ongoing in the UK & Brazil".
The university began clinical trials of the vaccine produced by Russia's Gamalei Institute of Epidemiology and Microbiology on June 18, 2020, stated Sputnik News. As of yet, there have been no complaints about side effects or adverse reactions. There are a few predictable side effects related directly to the vaccine's inoculation. The first group will be permitted to leave in two-three days and the second group will be discharged on July 20.
Earlier, on July 10, the Russian Defence Ministry said the volunteers being given the vaccine felt well, had no complaints, experienced no side-effects and were developing immunity to the coronavirus, as reported by TASS.
Queensland has recorded no new cases of coronavirus in the past 24 hours.